In a human colon cancer dataset, HOXA5 expression was lower in carcinomas compared with that in normal colon tissues, and high levels of HOXA5 expression was a prognostic factor for predicting improved relapse-free survival [9, 10]. This evidence concerns the gene HOXA5 and carcinoma.